SCHEMBL4145335

SCHEMBL4145335

O=C(O)CN1CCN([C@H](c2ccccc2)c2ccc(Br)cc2)CC1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 4/20 0.68
MEN1 O00255 5/20 0.67
KMT2A Q03164 5/20 0.67
IGF1R P08069 1/20 0.67
CACNA2D1 P54289 2/20 0.59
CACNA1B Q00975 2/20 0.59
CACNB1 Q02641 2/20 0.59
CACNA1C Q13936 2/20 0.59
NPSR1 Q6W5P4 2/20 0.56
ATM Q13315 1/20 0.56
PKM P14618 1/20 0.55
CACNA1G O43497 1/20 0.55
ALDH1A1 P00352 1/20 0.54
POLB P06746 1/20 0.54
KDM4E B2RXH2 1/20 0.54
OPRD1 P41143 3/20 0.53
OPRM1 P35372 2/20 0.53
OPRK1 P41145 1/20 0.53
OPRL1 P41146 1/20 0.53
LMNA P02545 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4139140 1.00 SLC6A9 (0.68) SLC6A9MEN1KMT2AIGF1RCACNA2D1
SCHEMBL4139144 1.00 SLC6A9 (0.68) SLC6A9MEN1KMT2AIGF1RCACNA2D1
Hydrochloric Acid SCHEMBL4156365 0.99 SLC6A9 (0.66) SLC6A9MEN1KMT2AIGF1RCACNA2D1
Hydrochloric Acid SCHEMBL4145669 0.99 SLC6A9 (0.66) SLC6A9MEN1KMT2AIGF1RCACNA2D1
Hydrochloric Acid SCHEMBL4145673 0.99 SLC6A9 (0.66) SLC6A9MEN1KMT2AIGF1RCACNA2D1
SCHEMBL1691475 0.91 SLC6A9 (0.74) SLC6A9MEN1KMT2ACACNA2D1CACNA1B
SCHEMBL4159395 0.88 SLC6A9 (0.67) SLC6A9MEN1KMT2AIGF1RCACNA2D1
SCHEMBL4144242 0.88 SLC6A9 (0.67) SLC6A9MEN1KMT2AIGF1RCACNA2D1
SCHEMBL4144245 0.88 SLC6A9 (0.67) SLC6A9MEN1KMT2AIGF1RCACNA2D1
Hydrochloric Acid SCHEMBL4151458 0.87 SLC6A9 (0.66) SLC6A9MEN1KMT2AIGF1RCACNA2D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735383-B2 Glycine transporter-1 inhibitors AMGEN INC. (US) 2014-05-27 US claimed
EP-2041088-B1 GLYCINE TRANSPORTER-1 INHIBITORS AMGEN INC (US) 2014-01-08 EP claimed
US-20120195985-A1 GLYCINE TRANSPORTER-1 INHIBITORS AMGEN INC. (US) 2012-08-02 US claimed
US-20090227595-A1 GLYCINE TRANSPORTER-1 INHIBITORS HITCHCOCK STEPHEN 2009-09-10 US claimed
CN-101479243-A Glycine transporter-1 inhibitors AMGEN INC (US) 2009-07-08 CN claimed
US-7538114-B2 Glycine transporter-1 inhibitors AMGEN INC. (US) 2009-05-26 US claimed
US-20080004289-A1 Glycine transporter-1 inhibitors AMGEN INC. 2008-01-03 US claimed
EP-2947067-A1 Glycine transporter-1 inhibitors Amgen, Inc (US) 2015-11-25 EP disclosed
EP-2565183-A1 Glycine transporter-1 inhibitors Amgen Inc. (US) 2013-03-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227595-A1 GLYCINE TRANSPORTER-1 INHIBITORS SLC18A2, SLC7A11, SLC6A5 SLC6A9 8/4885MEN1 2625/4885KMT2A 843/4885
US-20120195985-A1 GLYCINE TRANSPORTER-1 INHIBITORS SLC18A2, SLC6A5, SLC1A2 SLC6A9 6/4885MEN1 2632/4885KMT2A 947/4885
US-20080004289-A1 Glycine transporter-1 inhibitors SLC18A2, SLC7A11, SLC6A5 SLC6A9 8/4885MEN1 2625/4885KMT2A 843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.